Majaz et al [22] reported that GCN5 was frequently overexpressed in human hepatocellular carcinoma tissues and cell lines, and silence of GCN5 inhibited cell proliferation, cell cycle progression, and xenograft tumor formation. This evidence concerns the gene KAT2A and hepatocellular carcinoma.